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Introduction
• Different reasons why children need GH in 
comparison to adults
• Confusions re diagnosis and whether to treat
• Case studies























• Noticed to be short by Practice Nurses
• Referred to Paediatric Endocrinologist
o When did the Practice Nurse refer?








• Follow up in 4 months 
SGA
• SGA
o Small for gestational age
• Weight below 10th
percentile
• AGA
o Weight between 10 and 90th
percentiles (between 2.5kg 
and 4kg)
• LGA
o Weight above 90th percentile
• IUGR
o Deviation in expected growth 
pattern




• High dose GH therapy for 
a period of 2 years 
induces catch up growth
• Catch down growth has 
been reported if 
treatment is discontinued 
in childhood
• At risk of hypoglycaemia
• GH: 0.035mg/kg/day















• Smoking / alcohol / drugs
Age 2.27 years
July 2010
• Baselines all normal
• Decided to watch height velocity
o 8.6cm/yr
• Follow up 4 months
Age 2.61 years
November 2010
• Height velocity now 11.9cm/yr
• Watch and wait
• Follow up 6 months
Age 3.11 years June 2011 
(one year in the system)
• Height velocity 4.6 cm/yr
• More  baseline bloods
o Normal 
• Follow up 6/12
• Still too young for SGA GH treatment
Discussion
• What do you think the appropriate course of action 
is to take now? 
Age 3.63 years
December 2011
• Height velocity 6 cm/yr
• Decision made to undertake Glucagon stimulation 
test
o ? See if GHD 
February 2012
• Glucagon stimulation test
o Brought into the day ward




(two years in the system)
• Found to be GHD!
• Full range of GH devices shown and demonstrated 
to the child and family
o Licensed indications
o DVDs given to family to take him if indecisive
o CNS contact details given













0 5.9 187 3.5 4.2
60 4.23 525 3.0 3.7
90 4.4 374 3.2 4.1
120 2.4 269 3.0 3.6
150 3.13 227 2.9 3.4




• 4/52 prescription from the hospital
• CNS sends to relevant homecare company
• Letter to GP asking them to take on shared care, 
and continue prescribing of GH
• Patient will start around one month later
• VARIES FROM HOSPTIAL TO HOSPITAL
Patient journey
• From start to finish
AT LEAST TWO YEARS
POTENTIAL BARRIERS
o Missing clinic appointments
o Full clinics – delay in next appointment
o Waiting list for glucagon test
o Samples go missing
o Family indecisive re GH choice
• Want to come in again and see device
o Delay in prescription being done 
o Delay with health care company
o Funding requests from CCG
o GP refusal to prescribe
Discussion
• How do you think the patient journey for this child 
could have been made better?
• What factors do we need to consider before 
starting GH therapy in children?
Guidelines for GH therapy –
BEFORE starting





o HV after 1 year of treatment can 
be assessed
• Full commitment from 
family
• Involvement of CNS
o Counselling the child and family
o Assessing likelihood of 
compliance
o Patient choice of devices
o Teaching the daily injection
Guidelines for GH 
therapy - DURING
• Given subcutaneously in the evening, 7 days a 
week
• 4 monthly clinic visits
o Auxology and pubertal staging
• Compliance
• Home visit if HV disappointing
• 6-12 monthly IGF-1 measurement
o Dosage and compliance
• Annual bone age
• Discontinue GH at completion of 
growth (HV <2cm/yr)
• Re-test prior to transition
GHD - Children
• Due to the pituitary 
gland not being 
able to produce 
enough GH to 
facilitate the growth 
process
• Confirmed by a peak 




o Delayed bone age
Cancer treatment
Overall Late Effects of Brain Tumours
Late Effect Risk Factors Surveillance
Dental problems - Radiotherapy to field, including 
jaw (base of skull, cervical spine)
- Regular dental review
Hearing loss - Platinum chemotherapy
- +/- Radiotherapy to field, 
including middle ear (especially 
posterior fossa)
- Enquire re: speech and language 
development











-Pre-disposing syndromes eg: NF1
-High index suspicions of skin 
lesions (especially skin cancers, 
meningiomas, glial tumours) 
within radiotherapy fields
-Patient education and regular 
examination of skin lesions
Shunts (blocked or infected) - Inform patient of potential 
complications and symptoms
Thyroid function - Radiotherapy to field, including 
thyroid (base of skull, cervical 
spine)
-Clinical screening
-Annual thyroid function tests




• Most deficiencies are probably caused by the tumour 
itself, as much as surgery, radiotherapy or chemotherapy
• It can be difficult to know the exact causes and effects, 
but current research suggests..
Growth Hormone Deficiency
• The result of both tumour and radiotherapy
• Occurs more quickly after higher (rather 
than lower) radiation doses
• Older children, who’s growth and 
development is nearly finished, may get 
away without therapy in childhood
• The importance for it in adulthood is still 
under review:






• 17 year old boy – Tom
• 4 year history of fatigue
o Had swine flu age 13yrs, and ‘never regained energy’
o Complained of headaches, but ‘ignored as family history of migraines’
• Presented with a 6 week history of peripheral visual 
field loss – left, then right
Discussion






• Mostly cystic post-chiasmatic suprasellar mass, with 
a small solid calcified component anteriorly and on 
the right side.
• It elevates the anterior visual pathways and slightly 
favours the right side without eroding  through the 
floor of the third ventricle
• Appearances are typical of a craniopharyngioma
Craniopharyngioma
• Benign brain tumour
• Thought to form and 
grow from some 
misplaced cells in the 
brain close to the 
pituitary gland
• Presentation varies
o Most commonly occurring 
symptoms are headaches and 
blurred vision
Surgery
• 5 March 2014
o Cyst aspiration
• 12mls of fluid 










o Can be used for 
aspiration of cerebro
spinal fluid (CSF), or 
delivery of drugs
o Indwelling catheter into 
one of the lateral 
ventricles in the brain
Post op endocrine 
assessment
• Insulin Tolerance Test 14 March 2014
• Intact pituitary reserve except severe 
growth hormone deficiency
• Good peak cortisol
• Normal thyroid function
• Normal gonadal function
• No diabetes insipidus
Insulin Tolerance Test -
results
• Growth hormone therapy 
commenced April 2014
• Nordipen 1.0mg daily s/c
Discussion
• Should Tom be starting GH?
• Paediatric or adult dose?
o Near end of puberty
o Minimal growth left
Neurosurgical follow up
• Post operative MRI scan
o Small solid component at the anterior wall of the cyst
o Intimately associated with the pituitary stalk, the carotid vessels and the 
optic chiasm
• Complete surgical excision would be difficult
o Either transphenoidal or transcranial
• Radiotherapy proposed
o April 2014 – Proton beam therapy, Jacksonville, Florida
• Tom too old under NHS guidance as over 16
o Family planned to raise funds for treatment in USA
o Eligible for clinical trial 
• Month of pre treatment tests = treatment paid for
Further post operative 
follow up
• 27 March 14
o Sperm cryopreservation
• 6 May 2014 - Florida
o Standard Short Synacthen Test
• Cortisol: 0840 180nmol/l → 0900 380nmol/l
• FT4 0.7ng/dl, TSH 0.7mIU/ml
• Commenced:
o Hydrocortisone (oral) 5mg three times a day
o Thyroxine (oral) 75mcg once a day
Proton beam treatment
• Type of external beam 
radiotherapy that uses 
ionizing radiation
• Tumour is targeted with a 
beam of protons
• Protons
o Damage the DNA of the cells, 
halting the reproduction
o Due to their large mass
• Little lateral side scatter in 
the tissue
• All have a certain range
o Very few go beyond 
that distance




• May 17 2014 – July 9 2014
• 44 days of treatment
o 54 CGE (Gy) at 1.8 CGE per daily fraction
o Used a three field 3D conformal proton plan
Proton Beams
Proton beams





o Post treatment baseline
o Every 2/3 years minimum
• Neuroendocrine testing within 6 months
o Post treatment baseline
o Continue every 6/12 at least through puberty
• Ideally lifelong
o Pay particular attention to GH
• Ophthalmology and visual acuity
Endocrine follow up
• Back in the UK – July 2014




• Intensive emergency management teaching
oMedic Alert bracelet
oOngoing with school
o Translations into Spanish
Emergency management
Tom..
• Continue neuropsyschological and 
ophthalmological assessments
o Good cognitive assessments
• A* at GCSEs
• A Levels in Barcelona
• University to study mechanical engineering
• GH discontinued February 2015
• No gonadotrophin deficiency, but Testosterone low 
normal level 
o USA: 320ng/dl (238 – 850)
• Hydrocortisone increased 7.5 / 5 / 5mg
• Family
o Increased support wanted  - Barcelona
Continuing plan
• Stay off growth hormone
o ? Start adult GH
• Encourage Thyroxine compliance
• Observe for evolving gonadotrophin
deficiency
• Continue annual 24 hour cortisol profiles
o ? Increase hydrocortisone to 10 / 5/ 5
• Transition – now nearly 19years old
Discussion
• What is the adult endocrine nursing approach with 
a ‘child’ such as Tom coming to your clinic?
Tom today
Conclusion
• Differing reasons why children may be GHD
• Very different patient journeys
• Food for thought at transition
